Market Overview

Novogen Entered into Agreement to License & Assign Certain Preclinical Assets to Heaton-Brown Life Sciences​; Novogen to Receive 10% Equity in Heaton-Brown Life Sciences

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News

 

Related Articles (NVGN)